Thursday 17 August 2017

Immunohistochemistry: Helping in Cancer Diagnosis

Immunohistochemistry or IHC is a process that uses antibodies to detect antigens in the cells within the tissue section of heart, liver, and pancreas. The technique uses these antibodies, which can be identified and attach themselves to cell markers. These antibodies help technicians make precise identification of the numerous cancers. The IHC is widely used in medicine, especially in cancer diagnosis.

Innovation

HalioDx is a France-based company recently unveiled HalioDx Immunoscore CR technology, which combines immunohistochemistry with advanced imaging analysis. Immunoscore provides imaging analysis allowing the extraction of spatially-organized molecular tissue information. This technology works as a platform for various types of cancers as an immune response to tumors.

The Immunoscore CR assay can measure the density of two T lymphocyte populations namely CD3 + T cells and CD8+ cytotoxic T cells. The assay works on FFPE tissue, as a tumor resections or biopsies by combining immunohistochemistry along with high resolution image analysis systems. The assay is authenticated on many types of tumor.

The Immunoscore CR provides important information about adaptive immunity to human tumors. HalioDx Immunoscore technology is strong sensitive and standardized assay. This can further be used in clinical trials along with Good clinical laboratory practice (GCLP). Moreover, the main component of the Immunoscore CR technology has been developed to abide by companion diagnostic design control requirements as stated by UK and USA.

Market Overview

The immunohistochemistry (IHC) market is anticipated to be valued at USD 3.1 billion by 2025; according to a new study by Grand View Research, Inc. Prevalence of cancer is a major market driver. Analysis of chronic diseases, play a key role by predicting the prognosis of the tumors. IHC is further used in the identification of tumor cell proliferation, enzymes, tumor suppressor genes, and antigens among others.

Market Rivals

F. Hoffmann-La Roche Ltd, Merck Millipore, PerkinElmer, Inc., and Thermo Fisher Scientific Inc. are some of the major market players. They often take part in mergers & acquisitions to expand globally.

In-Depth research report on immunohistochemistry (IHC) market:

No comments:

Post a Comment

Ophthalmic Ultrasound Devices Market - Global Forecasts to 2026 by Grand View Research, Inc.

19-Mar-2020: The global ophthalmic ultrasound devices market size is expected to reach USD 728.7 million by 2026, according to a new repo...